Why the study?
The study evaluated the diagnostic value of neopterin, periostin, YKL-40, Tenascin-C, and Indolamine 2,3-dioxygenase as noninvasive biomarkers for malignant pleural mesothelioma.
Do levels of neopterin, periostin, YKL-40, Tenascin-C, and IDO differ between patients with malignant pleural mesothelioma and controls?
Do levels of neopterin, periostin, YKL-40, Tenascin-C, and IDO differ between patients with malignant pleural mesothelioma and controls?
Neopterin, periostin, YKL-40, Tenascin-C, and IDO are significantly elevated in malignant pleural mesothelioma and may serve as non-invasive diagnostic biomarkers.
Supports further investigation of these biomarkers for MPM diagnosis; leaves open their routine clinical use.
Introduction: Malignant pleural mesothelioma (MPM) is a malignant tumor that is associated mostly with asbestos exposure. The present study was to evaluates the diagnostic value of neopterin, periostin, YKL-40, Tenascin-C (TNC), and Indolamine 2,3-dioxygenase (IDO) as noninvasive markers of malign pleural mesothelioma. Methods: Included in the study were 30 patients diagnosed with malign pleural mesothelioma, and 25 people as a control group. Biomarker levels were determined using an enzyme immunoassay . A Mann-Whitney U test and Spearman correlation methods were used for the statistical analysis. Results: All evaluated biomarkers were found to be significantly higher in the MPM group than in the control group ( p < 0.05). There was no effect of such variables as gender, age or MPMsubtype on the parameters ( p > 0.05) in the patient group. All biomarkers were positively correlated with each other ( p < 0.001). Conclusions: The current non-invasive biomarkers that can be used in the diagnosis of MPM yielded significant results and can make important contributions to the early diagnosis of MPM.
No takes yet. Share an insight, caveat, or question.
Tanrıverdi et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: